Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q1 FY2023 Earnings Presentation
23 slides from Valiant Organics's earnings presentation, Aug 6, 2022
Slide 1: Valiant Organics Limited – Investor Presentation Cover Letter
•••• Valiant Organics Limited Date: August 06,2022 To, To, Listing/Compliance Department BSE LTD Listing/Compliance Department Phiroze Jeejeebhoy Towers, National Stock Exchange of Dalal Street, India Limited Mumbai- 400 001. "Exchange Plaza",Plot No.C/1, G Block Bandra-Kurla Complex, BSE CODE-54014
Slide 2: Earnings Presentation | Q1-FY23
Earnings Presentation | Q1-FY23
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries And Product Basket
Chemistries And Product Basket FY22 Revenue Share Hydrogenation Ammonolysis 31% Key Products: Industries Served: Key Products: Industries Served: • Ortho Anisidine • Dyes • Para Nitro Aniline • Dyes • Para Anisidine • Pigments • Ortho Chloro Para Nitro Aniline • Pigments • IPPCA • Pharmaceutical • M
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 27,000 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Capex Projects
Capex Projects Installed Capacity Approx. Capex Product Project Status Remarks (MT per month) (INR Mn) Commissioned Para Nitro Aniline (PNA) & Completing phase-wise • Expansion from 550 TPM to 750 TPM at Vapi plant Ortho Chloro Para Nitro 550 ~ 70 • Full capacity addition in progress Aniline (OCPNA)
Slide 9: Q1-FY23 Highlights
Q1-FY23 HIGHLIGHTS Valiant Organics Limited | August 2022 8
Slide 10: Q1-FY23 Consolidated Financial Highlights
Q1-FY23 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 2,660 Mn Operational Revenue INR 319 Mn Operating EBITDA 11.99% Operating EBITDA Margin INR 169 Mn Profit After Tax 6.35% PAT Margin INR 5.52/ Share EPS Valiant Organics Limited | August 2022 9
Slide 11: Q1-FY23 Operational Highlights
Q1-FY23 Operational Highlights • Q1-FY23 financials were impacted primarily due to the unfortunate blast at our Q1-FY23 Revenue Break-up – Chemistries Chlorination plant in Sarigam leading to shutdown for an extensive period of time, as well Others, 7% as subdued demand of our hydrogenation products
Slide 12: Key Chemistries: Revenues and Sales Volumes
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1, 200 1,048 1,036 824 752 250 900 300 900 784 1, 000 800 REVENUES 800 700 617 250 209 568 700 800 600 600 200 159 399 450 500 600 500 150 400 400 400 300 100 300 200 200 200 50 100 100 0 0 0 0 Q1-FY22
Slide 13: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q1-FY23 Q1-FY22 Y-o-Y Q4-FY22 Q-o-Q Revenue from Operations 2,660 2,441 9.0% 3,476 (23.5)% Total Expenses 2,341 1,937 20.9% 2,906 (19.4)% EBITDA 319 504 (36.7)% 570 (44.0)% EBITDA Margins (%) 11.99% 20.65% (866) Bps 16.40% (441) Bps O
Slide 14: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q1-FY23 Q1-FY22 Y-o-Y Q4-FY22 Q-o-Q Revenue from Operations 2,346 1,843 27.3% 2,906 (19.3)% Total Expenses 2,084 1,450 43.7% 2,462 (15.4)% EBITDA 262 393 (33.3)% 444 (41.0)% EBITDA Margins (%) 11.17% 21.32% NA 15.28% (411) Bps Other Inc
Slide 15: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | August 2022 14
Slide 16: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY20 FY21* FY22* Q1-FY23* Operational Income 6,749 7,548 11,533 2,660 Total Expenses 4,946 5,496 9,484 2,341 EBITDA 1,803 2,052 2,049 319 EBITDA Margins (%) 26.71% 27.19% 17.77% 11.99% Other Income 63 59 74 19 Depreciation 158 212 296 68
Slide 17: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (INR Mn) FY20 FY21* FY22* Particulars (INR Mn) FY20 FY21* FY22* EQUITY 4,007 5,086 6,489 Non-Current Assets 4,451 5,731 6,652 a) Equity Share Capital 121 272 272 a) Property, Plant and Equipment 2,729 4,967 5,303 b) Other Equity 3,736 4,747 5,856 b) Capital Wor
Slide 18: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY20 FY21* FY22* Q1-FY23* Revenue from Operations 5,836 5,742 9,484 2,346 Total Expenses 4,103 4,170 7,834 2,084 EBITDA 1,733 1,572 1,650 262 EBITDA Margins (%) 29.69% 27.38% 17.40% 11.17% Other Income 52 169 56 12 Depreciation 130 186 273
Slide 19: Standalone Balance Sheet
Standalone Balance Sheet Particulars (INR Mn) FY20 FY21* FY22* Particulars (INR Mn) FY20 FY21* FY22* EQUITY 3,875 5,023 6,031 Non-Current Assets 4,381 5,798 6,787 a) Equity Share Capital 121 272 272 a) Property, Plant and Equipment 2,525 4,771 5,085 b) Other Equity 3,736 4,747 5,755 b) Capital Work
Slide 20: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 80.00% 1,282 1,309 1,279 2,052 1, 400 2,049 14, 000 11,533 2,100 12, 000 1,803 70.00% 1,800 1, 100 10, 000 60.00% 1,500 50.00% 7,548 800 8, 000 6,749 1,200 40.00% 26.71%
Slide 21: Capital Market Information
Capital Market Information Share Price up to 30th June 2022 30% 20% 10% 0% -10% -20% -30% -40% -50% -60% -70% -80% Jul-21 Aug-21 Sep-21 Oct-21 Nov-21 Dec-21 Jan-22 Feb-22 Mar-22 Apr-22 May-22 Jun-22 Vali ant Sensex Price Data (As on 30th June, 2022) INR Shareholding pattern (As on 30st June, 2022) F
Slide 22: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all event
Slide 23: Thank You
THANK YOU Valiant Organics Limited | August 2022 22